The FDA cleared the Micromate system to use CT navigation in procedures such as biopsies and ablations.
Interventional Systems gets second 510(k) clearance for miniature robot Read More »
Members of the Senate Veterans Affairs Committee urged the CMS to rescind or revise its staffing proposal for nursing facilities on Thursday, warning the rules could cause facilities to close.
Senators urge CMS to withhold staffing mandate, citing negative impact on veteran care Read More »
A patient safety nonprofit used the findings to call for “long-term, nationally coordinated solutions” to stop persistent shortages.
Supply disruptions are delaying surgeries and compromising patient care, survey finds Read More »
A state hospital association says the updated charity care guidance, which would require facilities to offer subsidized care for patients regardless of residency, risks making Washington a “medical tourism destination.”
Washington hospitals sue state over expanded interpretation of a charity care law Read More »
The no-cash deal will combine Detroit-based Henry Ford Health with Ascension’s southeast Michigan and Genesys healthcare facilities and create an organization spanning across 550 sites.
Henry Ford, Ascension enter joint venture to create $10.5B system Read More »
En el vasto y misterioso mundo de la física, uno de los enigmas más intrigantes que ha cautivado a científicos, filósofos y pensadores durante décadas es el efecto de la conciencia en la materia. Este concepto desafía nuestra comprensión tradicional d …
El extraño vínculo entre la conciencia y la materia Read More »
Following a delay and an initial rejection, UCB’s IL-17A/IL-17F blocker bimekizumab was approved for moderate-to-severe plaque psoriasis, which will now be marketed with the brand name Bimzelx.
UCB Wins FDA Approval for Plaque Psoriasis Therapy After Regulatory Setbacks Read More »
North America’s largest pure-play distributor of scientific products, Thomas Scientific, has completed the acquisition of Lenexa, KS based forensics product provider Arrowhead Forensics.
Flare Therapeutics Inc. today announced that the first patients have been dosed in the company’s phase 1 study to assess the safety and tolerability of FX-909, a first-in-class small molecule inhibitor of peroxisome proliferator-activated receptor gamma (PPARG), a master regulator of the luminal lineage.
To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targeted cancer treatments, Thermo Fisher Scientific today announced a companion diagnostic (CDx) partnership with Boehringer Ingelheim.
